The most significantly different feature is that approximately 75% of patients with CTNNB1 loss of function mutations have mild visual defects, mostly characterized by astigmatism, hyperopia, or strabismus,[10] while the patient in this study suffered from severe ophthalmic disease resulting in complete loss of vision. This evidence concerns the gene CTNNB1 and Astigmatism.